Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy

R-CHOP chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma. We estimated the point prevalence of Pneumocystis pneumonia in non-Hodgkin lymphoma patients according...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tark, Choi, Sang-Ho, Kim, Sung-Han, Jeong, Jin-Yong, Woo, Jun Hee, Kim, Yang Soo, Sung, Heungsup, Kim, Mi-Na, Yoon, Dok Hyun, Suh, Cheolwon, Lee, Sang-Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080131/
https://www.ncbi.nlm.nih.gov/pubmed/23053189
http://dx.doi.org/10.1007/s00277-012-1592-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080131/
https://www.ncbi.nlm.nih.gov/pubmed/23053189
http://dx.doi.org/10.1007/s00277-012-1592-1

Ejemplares similares